Osteoarthritis Perspective

 
 
  • Osteoarthritis Phenotyping Makes Progress Karmela Kim Chan, MD, discusses recent efforts to phenotype osteoarthritis, which have not yet been applied successfully to match appropriate treatment to the appropriate patient population.
  • ACR 2021 Read clinically focused news coverage of key developments from ACR 2021
  • USPSTF Statement on Aspirin: Poor Messaging at Best Could the messaging around the U.S. Preventive Services Task Force's draft aspirin recommendations put some patients who likely benefit at risk?
  • Managing Hip Pain: Clinicians Debate Readers weighed in on Dr Vega's management of a patient with hip pain. Here's the crowdsourced opinion.
  • PANLAR 2021 Read clinically focused news coverage of key developments from PANLAR 2021.
  • More Rheumatology Patients Are Using Cannabis: Are You Ready? Karmela Kim Chan, MD, looks at the many unknowns in play regarding the use of and current state of knowledge about medical marijuana and cannabis-derived drugs in patients with rheumatic diseases.
  • Hip OA: What's the Best First Option? Dr Charles Vega has a patient with painful and lifestyle-limiting hip OA. Is he taking the right course of treatment?
  • How Often Should You Check Bone Mineral Density?   Osteopenia has a new name, and we're probably doing too many DEXA scans. Get up-to-date with The Curbsiders.
  • Fall Prevention Advice for Patients With Parkinson's Tai chi's emphasis on balance and strength may make it an excellent option for older adults.
  • OARSI 2021 Read clinically focused news coverage of key developments from OARSI Connect ‘21
  • CAC Scores, Lp(a), CRP: CV Screening in Real Life   Lipidologists Budoff and Baum discuss real-life implications of the CAC score and how to apply it, and other measures, to everyday patients.
  • ACR 2020 Read clinically focused news coverage of key developments from ACR 2020
  • Are We Shortchanging Patients With Obesity? Recent studies suggest that patients are capable of greater weight loss than doctors might be giving them credit for. We can help more people benefit than we currently do, says Dr Richard Plotzker.
  • Stop the Benzo: It's Worth the Screaming The potential benefits of benzodiazepines among older adults are simply outweighed by the risks. But is stopping them worth the fight?
  • Famous Patients: From Goethe to Beethoven Did you know about the physical and mental ailments of these famous artists?
  • Another Reason to Stop the PPI: Clinician Debate All of our readers agreed that a patient's PPI should be stopped. But their reasons for how and why varied.
  • Experts Unravel the 'Mysteries of Wrist Motion' Dr Scott Wolfe discusses his award-winning research in wrist kinematics and arthroplasty, and a novel prosthetic device that recently received FDA approval.
  • One Pill Won't Do It: Treating Chronic Pain: Bonus Content: Psychological Toll   Doctors discuss the emotional impact on patients who suffer from chronic pain.
  • One Pill Won't Do It: Treating Chronic Pain: The Road Ahead   Pain specialists discuss how emerging therapies and lifestyle adjustments can improve quality of life and overall outcomes of patients with chronic pain
  • Stop the PPI to Lower COVID-19 Risk? A patient wants to stop taking her proton pump inhibitor because she's heard that it increases risk for COVID. What would you recommend?